MY189987A - A percutaneous absorption composition - Google Patents

A percutaneous absorption composition

Info

Publication number
MY189987A
MY189987A MYPI2018700724A MYPI2018700724A MY189987A MY 189987 A MY189987 A MY 189987A MY PI2018700724 A MYPI2018700724 A MY PI2018700724A MY PI2018700724 A MYPI2018700724 A MY PI2018700724A MY 189987 A MY189987 A MY 189987A
Authority
MY
Malaysia
Prior art keywords
basic
percutaneous absorption
absorption composition
medicament
composition
Prior art date
Application number
MYPI2018700724A
Other languages
English (en)
Inventor
Miwa Yasushi
Hamamoto Hidetoshi
AKAZAWA Naoya
Original Assignee
Medrx Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medrx Co Ltd filed Critical Medrx Co Ltd
Publication of MY189987A publication Critical patent/MY189987A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
MYPI2018700724A 2015-08-29 2016-08-29 A percutaneous absorption composition MY189987A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP2015/074553 WO2017037813A1 (ja) 2015-08-29 2015-08-29 塩基性薬物とソルビン酸とを含有する経皮吸収組成物
PCT/JP2016/075203 WO2017038767A1 (ja) 2015-08-29 2016-08-29 経皮吸収組成物

Publications (1)

Publication Number Publication Date
MY189987A true MY189987A (en) 2022-03-22

Family

ID=58187853

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2018700724A MY189987A (en) 2015-08-29 2016-08-29 A percutaneous absorption composition

Country Status (16)

Country Link
US (3) US9974858B2 (enExample)
EP (1) EP3342423B1 (enExample)
JP (2) JP6259117B2 (enExample)
KR (1) KR20180039622A (enExample)
CN (1) CN107427509B (enExample)
BR (1) BR112018001387B8 (enExample)
CO (1) CO2018001831A2 (enExample)
ES (1) ES2864017T3 (enExample)
MX (1) MX388148B (enExample)
MY (1) MY189987A (enExample)
PH (1) PH12018500271A1 (enExample)
RU (1) RU2702356C2 (enExample)
SG (1) SG11201800043UA (enExample)
UA (1) UA123212C2 (enExample)
WO (2) WO2017037813A1 (enExample)
ZA (1) ZA201800296B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107427509B (zh) 2015-08-29 2021-06-15 美德阿利克斯株式会社 含有碱性药物和山梨酸的经皮吸收组成物
US11559519B2 (en) 2018-01-31 2023-01-24 Medrx, Co., Ltd. Tizanidine therapy system
US11186585B2 (en) 2018-08-17 2021-11-30 Kappa-Pharma LLC Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates
TWI772807B (zh) * 2019-05-27 2022-08-01 日商救急藥品工業股份有限公司 外用製劑
CA3149152A1 (en) * 2019-08-11 2021-02-18 Kappa-Pharma LLC Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates
CA3168199A1 (en) 2020-02-19 2021-08-26 Eri ICHIBAYASHI Transdermal absorption preparation
US12103639B2 (en) * 2021-06-03 2024-10-01 Sram, Llc Bicycle control system
US20240374544A1 (en) * 2021-08-30 2024-11-14 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for the transdermal administration of guanfacine comprising guanfacine and a mono-carboxylic acid
CA3232272A1 (en) * 2021-10-15 2023-04-20 Hans-Werner Wolf Transdermal therapeutic system for the transdermal administration of tizanidine
CN116370439A (zh) * 2022-04-01 2023-07-04 江苏山信药业有限公司 一种伐尼克兰透皮贴剂及其制备方法和其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61172830A (ja) * 1985-01-26 1986-08-04 Showa Denko Kk 皮膚外用剤組成物
CA2378385C (en) * 1999-07-27 2009-01-27 Hisamitsu Pharmaceutical Co., Inc. Patch formulation for external use including an acid addition salt of a basic drug
US20040142024A1 (en) 1999-07-27 2004-07-22 Hisamitsu Pharmaceutical Co., Inc. Patch formulation for external use
DE602005017753D1 (de) * 2004-03-19 2009-12-31 Mcneil Ab Mittel für die transdermale verabreichung von nikotin
JP4807974B2 (ja) * 2005-06-30 2011-11-02 帝國製薬株式会社 経皮吸収促進組成物
CN101032474B (zh) * 2006-03-06 2011-02-16 重庆医药工业研究院有限责任公司 一种治疗或预防神经系统疾病的雷沙吉兰透皮贴片及其制备方法
CN101143127A (zh) * 2007-10-25 2008-03-19 复旦大学 一种酚妥拉明外用制剂及其制备方法
CN103239721B (zh) 2007-11-22 2016-03-16 美德阿利克斯株式会社 包括基于脂肪酸的离子型液体作为活性成分的外用制剂组合物
JP5537412B2 (ja) 2008-02-27 2014-07-02 久光製薬株式会社 貼付製剤
WO2010016219A1 (ja) 2008-08-05 2010-02-11 株式会社メドレックス 塩基性薬効成分の脂肪酸塩、安息香酸塩を含有する外用剤とその製造方法
JP2012158521A (ja) * 2009-04-17 2012-08-23 Kureha Corp 外用剤
EP2476414B1 (en) * 2009-09-07 2015-03-04 NIPRO Patch Co., Ltd. Transdermally absorbable preparation
WO2011157449A1 (en) * 2010-06-18 2011-12-22 Merz Pharma Gmbh & Co. Kgaa Gel formulations for the topical use of 1-amino-alkylcyclohexane derivatives
US10543275B2 (en) * 2012-06-20 2020-01-28 Medrx Co., Ltd. Composition for patch preparation comprising drug, organic solvent, lipophilic mass base, and powder
JP2014125483A (ja) 2012-12-27 2014-07-07 Lion Corp 貼付剤
CN107427509B (zh) * 2015-08-29 2021-06-15 美德阿利克斯株式会社 含有碱性药物和山梨酸的经皮吸收组成物

Also Published As

Publication number Publication date
BR112018001387B1 (pt) 2023-09-05
US20170056502A1 (en) 2017-03-02
CN107427509B (zh) 2021-06-15
JPWO2017038767A1 (ja) 2017-09-07
US10588973B2 (en) 2020-03-17
EP3342423A4 (en) 2018-07-25
ES2864017T3 (es) 2021-10-13
RU2702356C2 (ru) 2019-10-08
UA123212C2 (uk) 2021-03-03
JP2017149782A (ja) 2017-08-31
US9974858B2 (en) 2018-05-22
US11382978B2 (en) 2022-07-12
BR112018001387A2 (pt) 2018-09-11
WO2017037813A1 (ja) 2017-03-09
EP3342423B1 (en) 2021-03-10
RU2018110617A3 (enExample) 2019-09-30
MX2018002015A (es) 2018-06-19
PH12018500271A1 (en) 2018-08-13
CN107427509A (zh) 2017-12-01
RU2018110617A (ru) 2019-09-30
ZA201800296B (en) 2019-04-24
US20200171156A1 (en) 2020-06-04
MX388148B (es) 2025-03-19
JP6259117B2 (ja) 2018-01-10
BR112018001387B8 (pt) 2024-03-05
US20180236082A1 (en) 2018-08-23
KR20180039622A (ko) 2018-04-18
EP3342423A1 (en) 2018-07-04
WO2017038767A1 (ja) 2017-03-09
SG11201800043UA (en) 2018-02-27
CO2018001831A2 (es) 2018-05-21

Similar Documents

Publication Publication Date Title
PH12018500271A1 (en) A percutaneous absorption composition
SA520411125B1 (ar) Nlrp مركبات وتركيبات لمعالجة حالات مرضية مرتبطة بنشاط
EA201690598A1 (ru) Аминогетероарил бензамиды в качестве ингибиторов киназы
EA201690287A1 (ru) 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом
BR112015029495A2 (pt) compostos heterocíclicos como inibidores da via de sinalização hedgehog
SG10201804652VA (en) Pyrrolidinones as herbicides
MD4807B1 (ro) Derivaţi de pirimidiniloxi-benzen utilizaţi ca erbicide
PH12015501957A1 (en) Pharmaceutical composition of s-ketamine hydrochloride
MX391539B (es) Proceso de compuesto antifungico.
EA201891409A1 (ru) Бензамидные соединения и их применение в качестве гербицидов
PH12015501316A1 (en) Heterocyclic compound
MY180526A (en) Pharmaceutical composition of s-ketamine hydrochloride
MX2017013880A (es) Derivados del acido tetrahidronaftiridinil propionico y usos de los mismos.
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
MX2017010624A (es) Derivado de amina ciclica y su uso farmaceutico.
PH12016502130B1 (en) Novel pyrrolopyrimidine compound or salt thereof, pharmaceutical composition containing same, especially agent for prevention and/or treatment of tumors etc based on nae inhibitory effect
MX368098B (es) Compuesto amidico.
MX2021015514A (es) Compuesto heterociclico.
PH12016500461A1 (en) Polyethylene glycol-containing composition
EA201491472A1 (ru) Фунгицидные соединения пиримидина
MX2018016339A (es) Compuestos heterociclicos antiinfecciosos y sus usos.
MX2019015747A (es) Compuesto heterociclico.
MX365021B (es) Composicion para tratar o prevenir enfermedades ocasionadas por permeabilidad vascular, que contiene como ingrediente activo imatinib o una sal farmaceuticamente aceptable del mismo.
MY197404A (en) Benzoic acid or a salt and derivative thereof for use in preventing or treating depression
EA201790067A1 (ru) Композиция для обработки волос